ArticleSignal transduction and targeted therapy2025
Pain management beyond opioids: a β-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development.
Eline Pottie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.